It's official. Weill Cornell Medical College, NewYork-Presbyterian Hospital, and their Minimally Invasive New Technologies Program (MINT) have teamed up with Lumendi Ltd. Get more information including the option to download the press release.
As a start-up, Lumendi Ltd is dedicated to producing next-generation endoscopic tools that:
– make complex gastrointestinal surgeries safer, and
– less expensive, while also
– improving patient outcomes.
You can download the two-page press release as a pdf (390 KB). Deutsche Version der Pressemitteilung
Exclusive worldwide license granted to Lumendi Ltd
Lumendi Ltd holds an exclusive worldwide license from Weill Cornell on the Endolumenal Surgical Platform (ESP) and related ancillary products. According to Dr Peter Johann, Chairman of Lumendi Ltd:
“Lumendi’s vision is to revolutionize digestive surgery by developing and making available tools and devices enabling minimally invasive gastrointestinal interventions.”
Formed in December 2014, Lumendi is collaborating with MINT to further develop these devices.
Jerome J DeCosse MD Distinguished Professor of Surgery (Weill Cornell Medical College) and executive director of the Center for Advanced Digestive Care (NewYork-Presbyterian/Weill Cornell Medical Center), Dr Jeffrey Milsom has stated:
“Current endoscopes don’t offer the same level of stability that ESP does… With this device, you can better control and manipulate the surgical environment inside the intestine.”
If you have a question or comment, please drop us a line in the comments below.